<P><B>Abstract</B></P><P>MazF is an mRNA interferase that cleaves mRNAs at a specific RNA sequence. MazF from <I>E</I>. <I>coli</I> (MazF‐ec) cleaves RNA at A and CA. To date, a large number ...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A107687130
2013
-
SCOPUS,SCIE
학술저널
874-883(10쪽)
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
<P><B>Abstract</B></P><P>MazF is an mRNA interferase that cleaves mRNAs at a specific RNA sequence. MazF from <I>E</I>. <I>coli</I> (MazF‐ec) cleaves RNA at A and CA. To date, a large number ...
<P><B>Abstract</B></P><P>MazF is an mRNA interferase that cleaves mRNAs at a specific RNA sequence. MazF from <I>E</I>. <I>coli</I> (MazF‐ec) cleaves RNA at A and CA. To date, a large number of MazF homologs that cleave RNA at specific three‐ to seven‐base sequences have been identified from bacteria to archaea. MazF‐ec forms a dimer, in which the interface between the two subunits is known to be the RNA substrate‐binding site. Here, we investigated the role of the two loops in MazF‐ec, which are closely associated with the interface of the MazF‐ec dimer. We examined whether exchanging the loop regions of MazF‐ec with those from other MazF homologs, such as MazF from <I>Myxococcus xanthus</I> (MazF‐mx) and MazF from <I>Mycobacterium tuberculosis</I> (MazF‐mt3), affects RNA cleavage specificity. We found that exchanging loop 2 of MazF‐ec with loop 2 regions from either MazF‐mx or MazF‐mt3 created a new cleavage sequence at (A/U)(A/U)AA and C in addition to the original cleavage site, A and CA, whereas exchanging loop 1 did not alter cleavage specificity. Intriguingly, exchange of loop 2 with 8 or 12 consecutive Gly residues also resulted in a new RNA cleavage site at (A/U)(A/U)AA and C. The present study suggests a method for expanding the RNA cleavage repertoire of mRNA interferases, which is crucial for potential use in the regulation of specific gene expression and for biotechnological applications. Proteins 2013. © 2012 Wiley Periodicals, Inc.</P>
Predicting permanent and transient protein–protein interfaces